These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. New insights on the function of SCF ubiquitin E3 ligases in the lung. Weathington NM; Mallampalli RK Cell Signal; 2013 Sep; 25(9):1792-8. PubMed ID: 23680451 [TBL] [Abstract][Full Text] [Related]
7. Assaying proteasomal degradation in a cell-free system in plants. García-Cano E; Zaltsman A; Citovsky V J Vis Exp; 2014 Mar; (85):. PubMed ID: 24747194 [TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-mediated proteasomal degradation in normal and malignant hematopoiesis. Heuzé ML; Lamsoul I; Moog-Lutz C; Lutz PG Blood Cells Mol Dis; 2008; 40(2):200-10. PubMed ID: 17919948 [TBL] [Abstract][Full Text] [Related]
10. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2. Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854 [TBL] [Abstract][Full Text] [Related]
11. Ubiquitin E3 Ligase FBXO9 Regulates Pluripotency by Targeting DPPA5 for Ubiquitylation and Degradation. Swenson SA; Dobish KK; Peters HC; Bea Winship C; Willow Hynes-Smith R; Caplan M; Wittorf KJ; Ghosal G; Buckley SM Stem Cells; 2024 Apr; 42(4):317-328. PubMed ID: 38227647 [TBL] [Abstract][Full Text] [Related]
12. Perilous journey: a tour of the ubiquitin-proteasome system. Kleiger G; Mayor T Trends Cell Biol; 2014 Jun; 24(6):352-9. PubMed ID: 24457024 [TBL] [Abstract][Full Text] [Related]
13. Regulation of pluripotency and cellular reprogramming by the ubiquitin-proteasome system. Buckley SM; Aranda-Orgilles B; Strikoudis A; Apostolou E; Loizou E; Moran-Crusio K; Farnsworth CL; Koller AA; Dasgupta R; Silva JC; Stadtfeld M; Hochedlinger K; Chen EI; Aifantis I Cell Stem Cell; 2012 Dec; 11(6):783-98. PubMed ID: 23103054 [TBL] [Abstract][Full Text] [Related]
14. Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets. Marteijn JA; Jansen JH; van der Reijden BA Leukemia; 2006 Sep; 20(9):1511-8. PubMed ID: 16926849 [TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligase on the biological properties of hematopoietic stem cell. Zhan Q; Wang J; Zhang H; Zhang L J Mol Med (Berl); 2023 May; 101(5):543-556. PubMed ID: 37081103 [TBL] [Abstract][Full Text] [Related]
16. Role of ubiquitin ligases in neural stem and progenitor cells. Naujokat C Arch Immunol Ther Exp (Warsz); 2009; 57(3):177-88. PubMed ID: 19479207 [TBL] [Abstract][Full Text] [Related]
18. The SCF-type E3 Ubiquitin Ligases as Cancer Targets. Kitagawa K; Kitagawa M Curr Cancer Drug Targets; 2016; 16(2):119-29. PubMed ID: 26560120 [TBL] [Abstract][Full Text] [Related]